Most patients notice reduced appetite within the first few weeks, but meaningful weight loss generally takes two to four months to become visible
202 A Phase 2a study of efocipegtrutide (HM15211), a new long-acting triple GLP-1/GIP/glucagon RA is currently being conducted to assess its use to treat non-alcoholic steatohepatitis
Eating slowly, chewing thoroughly, and avoiding lying down within 23 hours after meals can improve digestive efficiency
Even if you already take a GLP-1 medication, these tips can help you maximize the benefits of GLP-1
Body weight and adiposity
Further, while actual out of pocket costs can vary greatly, and a few drug manufacturers have instituted programs in attempt to make them more affordable, these medications can still run upward of $1,000 per month in some cases